Vascular endothelial growth factor-A is an Immunohistochemical biomarker for the efficacy of bevacizumab-containing chemotherapy for duodenal and jejunal adenocarcinoma

BACKGROUND: The efficacy and safety of bevacizumab-containing chemotherapy for patients with metastatic duodenal and jejunal adenocarcinoma (mDJA) are unclear. The present study aimed to evaluate the efficacy of bevacizumab and to explore immunohistochemical markers that can predict the efficacy of...

Descripción completa

Detalles Bibliográficos
Autores principales: Amano, Takahiro, Iijima, Hideki, Shinzaki, Shinichiro, Tashiro, Taku, Iwatani, Shuko, Tani, Mizuki, Otake, Yuriko, Yoshihara, Takeo, Sugimoto, Aya, Egawa, Satoshi, Yamaguchi, Shinjiro, Kinoshita, Kazuo, Araki, Manabu, Hirao, Motohiro, Sakakibara, Yuko, Hiyama, Satoshi, Ogawa, Hiroyuki, Nagaike, Koji, Murata, Jun, Komori, Masato, Okuda, Yorihide, Kizu, Takashi, Tsujii, Yoshiki, Hayashi, Yoshito, Inoue, Takahiro, Takahashi, Hidekazu, Mizushima, Tsunekazu, Morii, Eiichi, Takehara, Tetsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406832/
https://www.ncbi.nlm.nih.gov/pubmed/34465291
http://dx.doi.org/10.1186/s12885-021-08724-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406832/
https://www.ncbi.nlm.nih.gov/pubmed/34465291
http://dx.doi.org/10.1186/s12885-021-08724-5

Ejemplares similares